- Report
- November 2024
- 283 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- March 2025
- 180 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 382 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- January 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- December 2024
- 150 Pages
Global
From €3595EUR$3,950USD£3,082GBP
- Report
- October 2024
- 192 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- May 2024
- 318 Pages
Global
From €3822EUR$4,200USD£3,277GBP
- Report
- March 2025
- 192 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 400 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 250 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- May 2024
- 181 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- May 2024
- 182 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- August 2023
- 1500 Pages
Global
From €7963EUR$8,750USD£6,827GBP
- Report
- April 2024
- 318 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- October 2023
- 207 Pages
India
From €1797EUR$1,975USD£1,541GBP
€3595EUR$3,950USD£3,082GBP
- Report
- July 2023
- 284 Pages
Global
From €2503EUR$2,750USD£2,146GBP
€5006EUR$5,500USD£4,291GBP
- Report
- August 2021
- 104 Pages
Global
From €3891EUR$4,275USD£3,335GBP

The Antimicrobial Susceptibility Testing (AST) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. AST is used to determine the effectiveness of antibiotics against a particular strain of bacteria, and is used to guide clinical decisions in the treatment of infectious diseases. AST tests are used to identify the most effective antibiotic for a particular infection, and to detect the emergence of antibiotic resistance. AST tests are used in both clinical and research settings, and are becoming increasingly important as antibiotic resistance continues to rise.
The AST market is driven by the increasing prevalence of infectious diseases, the growing demand for rapid and accurate diagnosis, and the need for personalized medicine. The market is further supported by the increasing adoption of automated systems, which reduce the time and cost associated with manual testing.
Notable companies in the AST market include bioMérieux, Becton Dickinson, Thermo Fisher Scientific, Bruker, and Hologic. Show Less Read more